ARTICLE | Finance
Analyst picks & changes
October 10, 2011 7:00 AM UTC
Several analysts commented last week on Immunex Corp., in anticipation of the upcoming American Society of Clinical Oncology (ASCO) meeting, which will contain data on Pixykine, IMNX's fusion protein of IL-3 and GM-CSF for neutropenia and thrombocytopenia. ...